Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abiomed Inc
(NQ:
ABMD
)
293.34
+11.63 (+4.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 10, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
192,357
Open
289.18
Bid (Size)
292.97 (2)
Ask (Size)
293.38 (2)
Prev. Close
281.71
Today's Range
287.69 - 293.44
52wk Range
219.84 - 376.99
Shares Outstanding
45,460,884
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Abiomed: Q1 Earnings Insights
August 04, 2022
Abiomed (NASDAQ:ABMD) reported its Q1 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
ABIOMED Announces First Quarter Record Revenue of $277 Million, up 10% Year Over Year, up 12% in Constant Currency*
August 04, 2022
From
Abiomed, Inc.
Via
Business Wire
Performance
YTD
-19.92%
-19.92%
1 Month
+11.93%
+11.93%
3 Month
+23.44%
+23.44%
6 Month
-5.08%
-5.08%
1 Year
-15.38%
-15.38%
More News
Read More
Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification
July 14, 2022
From
Abiomed, Inc.
Via
Business Wire
Quant Ratings Updated on 97 Stocks
June 28, 2022
Via
InvestorPlace
Recap: Abiomed Q4 Earnings
April 28, 2022
Via
Benzinga
What 4 Analyst Ratings Have To Say About Abiomed
April 06, 2022
Via
Benzinga
Recap: Abiomed Q3 Earnings
February 03, 2022
Via
Benzinga
Abiomed to Host Investor Call on Heart Failure Opportunity With Impella 5.5 and Impella BTR Heart Pumps
June 14, 2022
From
Abiomed, Inc.
Via
Business Wire
Quant Ratings Updated on 85 Stocks
May 31, 2022
Via
InvestorPlace
Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference
May 31, 2022
From
Abiomed, Inc.
Via
Business Wire
Earnings Scheduled For February 3, 2022
February 03, 2022
Via
Benzinga
SCAI 2022 Scientific Sessions Highlight Impella Research, Advancements to Improve Cardiogenic Shock Outcomes
May 18, 2022
From
Abiomed
Via
Business Wire
Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year
April 28, 2022
From
Abiomed, Inc.
Via
Business Wire
A Preview Of Abiomed's Earnings
April 27, 2022
Via
Benzinga
World’s First Patient Implanted with Impella BTR Minimally Invasive Heart Pump
April 26, 2022
From
Abiomed
Via
Business Wire
Markets Rise Despite Another New 2-Year High For US 10-Year Treasury Note
April 19, 2022
Via
Benzinga
Abiomed Fourth Quarter Fiscal 2022 Earnings and Conference Call Notification
April 08, 2022
From
Abiomed, Inc.
Via
Business Wire
First Patient in Japan Treated with Impella 5.5 with SmartAssist
April 06, 2022
From
Abiomed, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
April 06, 2022
Via
Benzinga
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
April 05, 2022
Via
InvestorPlace
Abiomed to Host Investor Call on Impella ECP, the World’s Smallest Heart Pump at 9 French
March 21, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 08, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed's Return On Capital Employed Insights
February 04, 2022
Via
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Via
Benzinga
Abiomed Announces Record Revenue of $261 Million, up 13% Year Over Year
February 03, 2022
From
Abiomed, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.